These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12489620)

  • 1. Legal syringe purchases by injection drug users, Brooklyn and Queens, New York City, 2000-2001.
    Des Jarlais DC; McKnight C; Friedmann P
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S73-6. PubMed ID: 12489620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York.
    Fuller CM; Ahern J; Vadnai L; Coffin PO; Galea S; Factor SH; Vlahov D
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S77-82. PubMed ID: 12489621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
    Neaigus A; Zhao M; Gyarmathy VA; Cisek L; Friedman SR; Baxter RC
    J Urban Health; 2008 May; 85(3):309-22. PubMed ID: 18340537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut.
    Singer M; Baer HA; Scott G; Horowitz S; Weinstein B
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):81-9. PubMed ID: 9722813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacy syringe sale practices during the first year of expanded syringe availability in New York City (2001-2002).
    Finkelstein R; Tiger R; Greenwald R; Mukherjee R
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S83-7. PubMed ID: 12489622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies.
    Rudolph AE; Crawford ND; Ompad DC; Benjamin EO; Stern RJ; Fuller CM
    J Am Pharm Assoc (2003); 2010 Mar-Apr 1; 50(2):140-7. PubMed ID: 20199954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City.
    Fuller CM; Galea S; Blaney S; Ompad DC; Deren S; Des Jarlais D; Vlahov D
    Ethn Dis; 2004; 14(4):589-96. PubMed ID: 15724781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of syringe deregulation on sources of syringes for injection drug users: preliminary findings.
    Deren S; Cleland CM; Fuller C; Kang SY; Des Jarlais DC; Vlahov D
    AIDS Behav; 2006 Nov; 10(6):717-21. PubMed ID: 16642418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More pharmacists in high-risk neighborhoods of New York City support selling syringes to injection drug users.
    Coffin PO; Ahern J; Dorris S; Stevenson L; Fuller C; Vlahov D
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S62-7. PubMed ID: 12489618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal trends in spatial access to pharmacies that sell over-the-counter syringes in New York City health districts: relationship to local racial/ethnic composition and need.
    Cooper HL; Bossak BH; Tempalski B; Friedman SR; Des Jarlais DC
    J Urban Health; 2009 Nov; 86(6):929-45. PubMed ID: 19911283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding access to sterile syringes through pharmacies: assessment of New York's Expanded Syringe Access Program.
    Tesoriero JM; Battles HB; Klein SJ; Kaufman E; Birkhead GS
    J Am Pharm Assoc (2003); 2009; 49(3):407-16. PubMed ID: 19443321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Access to syringes for HIV prevention for injection drug users in St. Petersburg, Russia: syringe purchase test study.
    Fedorova EV; Skochilov RV; Heimer R; Case P; Beletsky L; Grau LE; Kozlov AP; Shaboltas AV
    BMC Public Health; 2013 Mar; 13():183. PubMed ID: 23452390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injection drug users report good access to pharmacy sale of syringes.
    Reich W; Compton WM; Horton JC; Cottler LB; Cunningham-Williams RM; Booth R; Singer M; Leukefeld C; Fink J; Stopka TJ; Corsi KF; Tindall MS
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S68-72. PubMed ID: 12489619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to pharmacy-based syringe purchase among injection drug users in Tijuana, Mexico: a mixed methods study.
    Pollini RA; Lozada R; Gallardo M; Rosen P; Vera A; Macias A; Palinkas LA; Strathdee SA
    AIDS Behav; 2010 Jun; 14(3):679-87. PubMed ID: 20300820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access.
    Coffin PO; Linas BP; Factor SH; Vlahov D
    J Urban Health; 2000 Dec; 77(4):781-93. PubMed ID: 11194317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple access to sterile syringes for injection drug users: vending machines, needle exchange programs and legal pharmacy sales in Marseille, France.
    Moatti JP; Vlahov D; Feroni I; Perrin V; Obadia Y
    Eur Addict Res; 2001 Mar; 7(1):40-5. PubMed ID: 11316925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sterile syringe for every drug user injection: how many injections take place annually, and how might pharmacists contribute to syringe distribution?
    Lurie P; Jones TS; Foley J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S45-51. PubMed ID: 9663623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What do pharmacists think about New York state's new nonprescription syringe sale program? Results of a survey.
    Klein SJ; Harris-Valente K; Candelas AR; Radigan M; Narcisse-Pean M; Tesoriero JM; Birkhead GS
    J Urban Health; 2001 Dec; 78(4):679-89. PubMed ID: 11796814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syringe source, use, and discard among injection-drug users in New Haven, Connecticut.
    Khoshnood K; Blankenship KM; Pollack HA; Roan CT; Altice FL
    AIDS Public Policy J; 2000; 15(3-4):88-94. PubMed ID: 12189714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syringe distribution to injection drug users for prevention of HIV infection: opinions and practices of health care providers in New York City.
    Coffin PO; Fuller C; Blaney S; Vadnai L; Miller S; Vlahov D
    Clin Infect Dis; 2004 Feb; 38(3):438-41. PubMed ID: 14727219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.